Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Abbott Faces New Investor Class Action Lawsuits Over Similac Recall Not only did Abbott ignore safety warnings, but aggressively marketed unsafe infant formula products to new parents for years, the investor class action lawsuits claim. June 30, 2023 Irvin Jackson Add Your Comments Abbott Laboratories and its chief officers face two new investor class action lawsuits over a Similac recall last year, accusing them of damaging the company’s interests and value to investors, by failing to make sure infant formula products distributed to families nationwide were safe. The lawsuits stem from widespread contamination of Similac, Alimentum and EleCare formula, which sickened hundreds of babies nationwide, resulted in a massive recall and a temporary shutdown of Abbott’s Sturgis, Michigan manufacturing facility. The investors indicate that the company’s actions have caused billions of dollars in damage to Abbott’s value since 2019, due to the “illegal, unsafe and unethical production and sale of Infant formula products” in the U.S. One complaint (PDF) was filed by the International Brotherhood of Teamsters Local No. 720 Pension Fund and the Southeastern Pennsylvania Transportation Authority. The other complaint (PDF) was filed by the Comptroller of New York State as the trustee and administrative head of the state and local retirement system. Both lawsuits were filed on June 27 in the U.S. District Court for the Northern District of Illinois. Similac Recall Over Cronobacter and Salmonella Contamination Abbott Laboratories recalled Similac, Alimentum and Elecare formula products in February 2022, after it was confirmed that powdered formula manufactured at a Michigan facility was contaminated with Salmonella Newport and Cronobacter sakazakii bacteria. At least two infant deaths and hundreds of illnesses have been reported by parents who fed the recalled formula to their children, and subsequent investigations have revealed Abbott ignored industry safety standards and best practices at its facility for years, endangering children for the sake of profits. Shortly after the Similac recall, lawsuits were filed by families of babies who experienced problems. However, a number of Similac recall class action lawsuits were also filed, seeking economic damages for all consumers who purchased the contaminated formula, even if no injuries resulted from the contamination. BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in the complaints, the U.S. Judicial Panel on Multidistrict Litigation (JPML) has established centralized pretrial proceedings for all lawsuits over the Similac recall brought throughout the federal court system, consolidating the cases as part of an MDL before U.S. District Judge Matthew F. Kennelly in the Northern District of Illinois. The investor lawsuits accuse Abbott of ignoring safety problems at the facilities for years, some details of which were uncovered by FDA inspections months before the recall was announced. According to allegations in the complaints, Abbott’s leading officers and board members ignored these problems, putting short-term profits above both the safety of its vulnerable consumers and above the company’s long-term health and reputation, thus negatively impacting the company’s value and the value of investments in the company. The investors say that, in addition to unsafe practices at the Sturgis facility, Abbott used aggressive and amoral marketing tactics to convince new mothers to use its products. Through these tactics, investors claim Abbott deceived mothers into thinking its infant formula products are safer than they actually are, particularly its cow’s milk-based products, which have been linked to an increased risk of necrotizing enterocolitis (NEC) in preterm infants. “Notably, the Board and the Company’s management have authorized Abbott to pursue these marketing tactics for decades, and therefore, they are now ingrained as part of the Company’s culture,” the lawsuits state. “As such, those tactics, which are unethical and violate the Company’s corporate governance policies, while also potentially constitute illegal anti-competitive actions, continue unabated at Abbott while the Individual Defendants served as Abbott’s directors and officers.” The lawsuits accuse Abbott and its officers of breaches of fiduciary duty, and also accuses some of the officers of insider trading, resulting in billions of dollars in losses to the company’s value and, thus, their investments. Other Similac Recall Class Action Lawsuits Dismissed The new complaints come about a month after Judge Kennelly granted a motion to dismiss some Similac recall class action lawsuits filed by purchasers of the recalled infant formula products. However, those claims were from buyers who sought economic damages and refunds for purchasing infant formula which may have had no inherent value and potentially endangered their children’s lives. Abbott’s motion to dismiss argued that plaintiffs failed to adequately prove standing, meaning they suffered direct injury, and could not plausibly argue that the products were defective. Judge Kennelly’s May 22 order dismissed 10 Similac class action lawsuits. July 2023 Similac Recall Lawsuit Update As part of the coordinated management for the remaining Similac injury lawsuits, it is expected that Judge Kennelly will establish a bellwether trial program, where small groups of representative claims are prepared for early trial dates. While the outcome of these bellwether trials will not be binding on other cases, they will be used to help gauge how juries are likely to respond to evidence and testimony which could be repeated in hundreds of separate trials, and may help form the basis of a Similac recall settlement agreement. A similar process has been established in a separate federal MDL established for all Similac lawsuits over NEC diagnosed among premature infants fed the cow’s milk-based infant formula. Tags: Abbott Laboratories, Baby Formula Recall, Cronobacter, Food Poisoning, Infant Death, Infant Formula, Investor, Investor Lawsuit, Necrotizing Enterocolitis, Similac, Similac Recall Image Credit: Jonathan Weiss / Shutterstock.com Find Out If You Qualify for Infant Formula NEC Compensation More Baby Formula Lawsuit Stories Mead Johnson Must Face Enfamil NEC Lawsuit in Missouri State Court July 8, 2025 NEC Formula Lawsuit Set To Go Before Jury in Aug. 2025 June 23, 2025 Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ June 17, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: today) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025) Judge Extends Deadlines in PFAS Lawsuits Over Liver Cancer, Thyroid Cancer (Posted: today) A federal judge has extended deadlines for parties involved in firefighting foam lawsuits to complete discovery and expert reports on liver and thyroid cancer injuries. MORE ABOUT: AFFF LAWSUITPFAS Exposure During Pregnancy Linked to High Blood Pressure in Children: Study (06/26/2025)PFAS Drinking Water Lawsuit Filed by 16 Plaintiffs Over Testicular Cancer, Kidney Cancer, Ulcerative Colitis Side Effects (06/23/2025)AFFF Chemicals May Accelerate Spread of Cancer, Reduce Drug Effectiveness: Study (06/13/2025) Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: today) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)
Judge Extends Deadlines in PFAS Lawsuits Over Liver Cancer, Thyroid Cancer (Posted: today) A federal judge has extended deadlines for parties involved in firefighting foam lawsuits to complete discovery and expert reports on liver and thyroid cancer injuries. MORE ABOUT: AFFF LAWSUITPFAS Exposure During Pregnancy Linked to High Blood Pressure in Children: Study (06/26/2025)PFAS Drinking Water Lawsuit Filed by 16 Plaintiffs Over Testicular Cancer, Kidney Cancer, Ulcerative Colitis Side Effects (06/23/2025)AFFF Chemicals May Accelerate Spread of Cancer, Reduce Drug Effectiveness: Study (06/13/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)